Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age
Clinical trial NCT04544267 · TERMINATED
Trial details
- NCT number
- NCT04544267
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2021-06-02
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.